1Brownell J,Casale TB.Anti-IgE therapy[J].Immunol Allergy Clin North Am,2004,24(4):551-568.
2Hohlfeld JM,Schmiedl A,Erpenbeck VJ.Eosinophil cationic protein alters pulmonary surfactant structure and function in asthma[J].J Allergy Clin Immunol,2004,113 (3):496-502.
3Stelmach I,Majak P,Grzelewski T,et al.The ECP/Eo count ratio in children with asthma[J].J Asthma,2004,41(5):539 -546.
4Shirai T,Suzuki K,Inui N,et al.Th1/Th2 profile in peripheral blood in atopic cough and atopic asthma[J].Clin Exp Allergy,2003,33:84-89.
5Tanaka H,Komai M,Nagao K,et al.Role of interleukin-5 and eosin-ophils in allergen-induced airway remodeling in mice[J].Am J Respir Cell Mol Biol,2004,31:62-68.
7Dekorte CJ.Current and emerging therapies for the management of chronic inflammation in asthma[J].Am J Health Syst Pharm,2003,60:1949-1959.
8Hong SJ,Lee SY,Kim HB,et al.IL-5 and thromboxane A2receptor gene polymorphisms are associated with decreased pulmonary function in Korean children with atopic asthma[J].J Allergy Clin Immunol,2005,115(4):758-763.
